Welcome : Guest

Concordia International Corporation (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Concordia International Corporation, which is principally a Specialty Pharmaceutical Company. Illustrated with 49 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-66013
Price: $2450
Company Type: Public
Pages: 53
Date: March 2017
Market Data Tables: 49

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Concordia International Corporation's Sales by Business Segment (2015) in US$ Thousands for Pharmaceuticals Product Markets (Concordia North America, Concordia International, and Orphan Drugs)......5
Pharmaceutical Licensed Drugs......6
Table 2: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......6
Table 3: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......7
Rheumatoid Arthritis......8
Table 4: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......8
Atrial Fibrillation......9
Table 5: Global Atrial Fibrillation / Electrophysiology Market (2014) in US$ Million......9
Table 6: Atrial Fibrillation Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for EP Ablation, EP Diagnostics, EP Mapping & Recording Systems, EP Mapping & Recording Systems, Access, ICE, and Others......10
Cardiology......11
Table 7: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......11
Table 8: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......12
Table 9: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......13
Table 10: Cardio Vascular Diseases (CVD) Market by Cause of Death in the US (2015) - Percentage Share Breakdown by Volume for Coronary Heart Disease, Diseases of the Arteries, Heart Failure, High Blood Pressure, Stroke, and Others......14
Systemic Lupus Erythematosus with Benlysta......15
Table 11: Systemic Lupus Erythematosus with Benlysta Market by Category in the US (2015) - Percentage Share Breakdown by Value for Mild Systemic Lupus Erythematosus (excluded in target population), Moderate Systemic Lupus Erythematosus, and Severe Systemic Lupus Erythematosus......15
Epilepsy Therapeutics......16
Table 12: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......16
Seizure Disorder......17
Table 13: Seizure Disorder Market by Type of Drug in the US (2015) - Percentage Share Breakdown by Value for Carbamazepine, Clonazepam, Gabapentin, Lamotrigine, Levetiracetam, Valproic Acids and Others......17
Orphan Disease Therapeutics......18
Table 14: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......18
Cancer Drugs......19
Table 15: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......19
Table 16: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......20
Cancer Market......21
Table 17: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......21
Table 18: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......22
Table 19: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......23
Table 20: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......24
Table 21: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......25
Table 22: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......26
Table 23: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......27
Table 24: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......28
Cancer Patients......29
Table 25: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......29
Table 26: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......30
Table 27: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......31
Table 28: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......32
Table 29: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......33
Table 30: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......34
Table 31: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......35
Table 32: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......36
Table 33: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......37
Table 34: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......38
Cancer-Associated Mucositis......39
Table 35: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......39
Pharmaceutical Licensed Drugs......40
Table 36: Market Shares of Leading New Pharmaceutical Licensed Drug Companies by Value Sales Worldwide (2014) - Percentage Breakdown for C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Gilead Sciences, and Others......40
Epilepsy Therapeutics......41
Table 37: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......41
Orphan Disease Therapeutics......42
Table 38: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......42
Cancer Drugs......43
Table 39: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......43
Table 40: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......44
Table 41: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......45
Table 42: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......46
Table 43: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......47
Cardiology Therapeutics......48
Table 44: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......48
Head Lice......49
Table 45: Market Shares of Leading Prescription for Treatment of Head Lice in the US (2015) - Percentage Share Breakdown by Value for Generics, Natroba, Sklice, Ulesfia and Others......49
Table 46: Market Shares of Leading Prescription for Treatment of Head Lice in the US (2015) - Percentage Share Breakdown by Volume for Ovide, Sklice, Ulesfia and Others......50
Table 47: Concordia Healthcare Corporation's Sales by Product (2015) - Percentage Share Breakdown by Value for Dibenzyline, Donnatal, Lanoxin AG, Nilandron, Plaquenil and Other Products......51
Table 48: Concordia Healthcare Corporation’s Revenues by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Blockbuster Drugs, Mid-Sized Drugs and Small Drugs......52
Table 49: Concordia Healthcare Corporation’s Head Lice Prescription Segment Market by Therapy in the US (2015) - Percentage Share Breakdown by Volume for Lindane, Sklice, Stromectol, Ulesfia and Others......53